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Background & aims: : Infusion of fat into the small intestine induces satiety. Reducing fat droplet size
accelerates fat digestion, but the effect on satiety after ileal fat infusion is not known.
The aim of the study was to compare the effects of fat emulsions differing in droplet size (ﬁne, coarse)
infused in either duodenum or ileum on satiety, gastric emptying and peptide secretion.
Methods: In a randomized single-blind crossover study 15 healthy volunteers received, after intubation
with a nasoileal tube, 4 different treatments on 4 consecutive days. After consumption of a liquid meal,
6 g of ﬁne or coarse fat emulsion was infused into duodenum or ileum. Study parameters were satiety,
gastric emptying and gut peptides. These parameters were statistically evaluated using ANCOVA.
Results: In the duodenum, Fine emulsion signiﬁcantly reduced hunger, increased fullness, delayed gastric
emptying, but did not affect peptide secretion versus Coarse. In the ileum, Fine emulsion did not affect
hunger, fullness, or gastric emptying, but signiﬁcantly increased peptide secretion versus Coarse.
Conclusions: Compared to larger fat droplets, smaller droplets signiﬁcantly affect satiety, gastric emptying
and gut peptide release, but with the effect being dependent on the intestinal location of fat delivery.
Dutch Trialregister: NTR1515.
 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
Open access under the Elsevier OA license.1. Introduction
Infusion of fat into the small intestine inﬂuences food intake,
satiety parameters and gastrointestinal function.1 Addition of orli-
stat, a lipase inhibitor that prevents hydrolysis of triacylglyceroles
(TAG) to fatty acids (FA), abolishes these effects.2e4 This demon-
strates that for fat to induce changes in satiety and food intake,
hydrolysis is a necessary step. The presence of fatty acids is sensed
by the small intestinal mucosa, which leads to secretion of gut
peptides, such as CCK and PYY, or direct activation of neural (vagal)nted in this paper were pre-
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for Clinical Nutrition and Metabolafferents.1 These so-called satiety factors then increase satiety and
reduce food intake, but also cause a delay in gastric emptying.
A recent study by Armand et al.5 has shown that reducing the
droplet size of a fat emulsionmay increase fatty acid sensing. Lipase
is active on the surface of a fat droplet, and a smaller droplet size
will increase total emulsion surface area, thereby allowing the rate
of fat hydrolysis to increase (as in a state of lipase abundance in the
duodenum surface area will become the rate-limiting step).
Armand et al. observed that inhibition of gastric emptying is more
pronounced after smaller droplets compared to larger fat droplets,
suggesting an increase in fatty acid sensing. Additional evidence is
provided by Ledeboer et al.,6 who showed that reducing emulsion
droplet size signiﬁcantly increased secretion of CCK. Taken
together, these studies suggest that a reduction in fat droplet size
may increase the satiating and anorectic effects of a fat load.
This was recently conﬁrmed by Seimon et al.,7 who demon-
strated that, after duodenal infusion, fat droplet size affects satiety,
peptide secretion and motility. In their study, these authors
compared a small droplet (0.26 mm) soy bean emulsion (intralipid)
to two canola oil emulsions with larger droplets (30 mm, 170 mm).
After duodenal infusion, the smaller droplet emulsion had moreism. Open access under the Elsevier OA license.
Fig. 1. Study outline for the experiment. The study consisted of four treatments in
randomized order. Each subject started each test day by consuming a 145 kcal fat-free
liquid meal. On two of the test days, a duodenal fat infusion was scheduled from
t ¼ 30e90 min, and on the other two test days, an ileal fat infusion was scheduled from
t ¼ 105e165 min. Each fat infusion consisted of 6 g of either small (ﬁne emulsion:
0.65 m) or large (5.40 m) fat droplets. Throughout the test day, blood was sampled for
gut peptide analysis and satiety was measured by VAS questionnaires. Gastric
emptying was measured by the 13C breath test.
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compared to the larger droplet-emulsions. In that study, the fat
type (fat saturation) differed between the experiments and satiety
results might have been confounded by the occurrence of gastro-
intestinal symptoms.7
The duodenum is the most extensively studied location
with regard to small intestinal satiety mechanisms in response
to nutrients. Welch et al. have demonstrated that entry of nutrients
into the ileum also has potent effects on satiety and food intake
through activation of the ileal brake.8,9 We have previously
demonstrated that the effects of ileal fat infusion on satiety are
larger than these of fat infused into the duodenum.10 Furthermore,
a satiating effect was already demonstrated after infusion of a very
small amount of fat.11
The effect of fat droplet size during ileal fat infusion on satiety
and on peptide secretion has never been investigated. Therefore,
the present study was designed to compare the effect of emulsions
differing in droplet size on (1) satiety and on (2) GI peptide release
and motility with the emulsions infused into duodenum or ileum.
We hypothesize that reducing lipid droplet size will (1) increase the
effects on satiety, and (2) increase gut peptide secretion and gastric
emptying, through increased fatty acid sensing.
2. Materials and methods
2.1. Subjects
Healthy volunteers aged between 18 and 55 yrs with a BMI
between 18 and 32 kg/m2 were recruited by advertisement.
Restrained eaters (as assessed by the Dutch Eating Behaviour Ques-
tionnaire12) and subjects who reported that they were following
either a weight-reduction diet or a medically-prescribed diet were
excluded from participation. Subjects who were taking medication
that may have inﬂuenced appetite and sensory function or who
reported metabolic or endocrine disease, gastrointestinal disorders
or a history of medical or surgical events that may have affected
study outcome were also excluded. Informed consent was obtained
from each individual, and the study protocol was approved by the
local Medical Ethics Committee. Seventeen subjects met the inclu-
sion criteria. Two volunteers dropped out during the study: one due
to discomfort during catheter positioning and one due to failure to
position the tip of the catheter beyond the ligament of Treitz (ﬂexura
duodenojejunalis). Fifteen healthy volunteers (12 female, mean age
23 yrs, mean BMI 21.6 kg/m2) completed the protocol. Pregnancy
was excluded in all female volunteers by urine test.
2.2. Study design
In this single-blind randomized controlled crossover design, 6 g
of ﬁne or coarse oil emulsionwas administrated into the duodenum
or into the ileum. The study design is shown in Fig. 1.
2.3. Protocol
The study protocol consisted of ﬁve consecutive days. On
Monday, subjects arrived at 12:00 h for catheter placement. The
catheter for ileal intubation was a 290-cm-long rubber silicon 9-
channel (8-lumen, 1 balloon inﬂation channel, diameter 3.5 mm)
catheter custom-made by Dentsleeve International Ltd (Mis-
sissauga, Ontario, Canada). The functional length of the catheter
was 240 cm, with an additional 50 cm connection segment. The
catheter contained side-holes at 0, 10, 20, 30, 115, 130, 145 and
160 cm from the tip and had an inﬂatable balloon (maximum
inﬂation capacity 10 ml) at the distal tip. At least one of the four
proximal side-holes (usually at 145 or 160 cm) was positioned inthe duodenum, and was used for the duodenal infusion. The three
distal side-holes (0, 10, 20 cm) reaching into the ileumwere used to
administer placebo (see below) or fat emulsion in the ileum.
Through an anaesthetized nostril, the catheter was introduced into
the stomach, and allowed to pass through the pylorus to the ileum
by peristalsis. After passing the ligament of Treitz, a small balloon at
the tip was inﬂated to facilitate passage of the catheter to the ileum.
During the day, the subject was offered sugared tea or coffee to
stimulate peristalsis. The tip was placed in the ileum (at least
120 cm distal from Treitz). During the positioning and before every
test day, the position of the catheter was checked by ﬂuoroscopy.
We used the distance from the tip to the pylorus to verify place-
ment of the tip of the catheter into the ileum.
2.4. Test day (Fig. 1)
On each of the four consecutive test days, the subject arrived at
the laboratory at 8:00 h following an overnight fast. First, correct
position of the catheter was veriﬁed by ﬂuoroscopy. Then, a venous
catheter was placed in a forearm-vein for collection of blood
samples. At 8:45 h (t ¼ 15 min), a basal visual analogue scale
(VAS; see under ‘Satiety’ for details) score was taken, and at 9:00 h
a basal blood sample. Immediately after this (at t ¼ 0 min), the
breakfast (fat-free Slim$Fast Optima Ready To Drink (RTD): 325 ml,
145 Kcal, Unilever, Covington, TN, USA) was consumed within
15 min. To this breakfast, 150mg Sodium [1-13C]-acetate was added
in order to measure gastric emptying half time (T1/2).
The duodenal infusion started 30 min after the start of the
breakfast, and lasted for 60 min till t ¼ 90 min. This infusion was
given through the infusion port which was located just distal from
the pylorus. The ileal infusion, which was perfused through the
most distal infusion ports, started at t ¼ 105 min, and lasted till
t ¼ 165 min. Infusion rate in both cases was 1 ml/min or 0.9 kcal/
min. Each day either the ileum or the duodenumwas perfused with
an emulsion, consisting either of ﬁne or coarse droplets. When the
duodenum was perfused with emulsion, the ileum was perfused
with saline and vice versa. Subjects were unaware of the timing and
the nature of the infusion.
At 14:45 h, the intravenous cannula was removed, and subjects
were allowed to go home. They received an evening meal from
which they were allowed to consume freely till 22:00 h.
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chosen to represent the physiologic postprandial period of
maximum exposure of respectively the duodenum and ileum to
fat.13,14 Goebell et al. demonstrated that delivery of a meal marker
to the ileumwas at it’s maximum at 120e165 min after the meal.14
We performed an explorative study on the timing of arrival of the
low energy liquid meal (Slim$Fast) in the cecum and found a mean
arrival time of 110 min after ingestion (data not published). The
amount of fat used in the present study was based on the use of
meal replacers that regularly contain 6 g fat maximally per portion.
2.5. Satiety
The volunteers rated their feelings of hunger, satiety, appetite
for a meal, fullness, appetite for a snack by means of a mark on 64-
mm line scales using an EVAS (Electronic Visual Analogue Scale,
iPAQ).15 This scale was anchored at the low end with the most
negative or lowest intensity feelings (e.g., “not at all”), and with
opposing terms at the high end (e.g., “very high”) as described by
Flint et al.16 Measurements were taken at regular intervals during
the test day.
2.6. Gastrointestinal symptoms
Gastrointestinal disturbances (nausea, abdominal pain, bloating,
heartburn, abdominal cramps) and general symptoms (headache,
malaise, dizziness, and fatigue) were scored just before breakfast
consumption and every 2 h thereafter on a 4-point scale (0 ¼ not,
1 ¼ mild, 2 ¼ moderate, 3 ¼ severe) using EVAS.
2.7. Gastric emptying
Gastric emptying was measured by 13C stable isotope breath
test. The parameters used were gastric emptying half time (T1/2)
which is the moment at which half of the marker has been emptied
from the stomach. For this purpose, 150 mg of sodium [1-13C]-
acetate (99%; Cambridge Isotope laboratories/ARC Laboratories,
Amsterdam) was added to the RTD ingested at t ¼ 0. One basal
breath sample was taken at t ¼ 0 before consuming the RTD, and
subsequent samples were taken at 15 min intervals for the ﬁrst 2 h,
and at 30min intervals thereafter until t¼ 240min. Breath samples
were collected using plasticized aluminium bags, and analysed by
InfraRed ISotope analysis (IRIS, Wagner Analisen Technik, Bremen,
Germany). Half time of gastric emptying was calculated after curve
ﬁtting using methods described by Braden et al.17
2.8. Hormone assays
Blood samples were drawn at regular intervals throughout the
test day. Total plasma PYY was measured by radioimmunoassay as
described previously.18 The detection limit is 10 pmol/l. The intra-
assay variation ranges from 1.8 to 15.6% and the inter-assay varia-
tion from 9.5 to 27.8%.18 Plasma CCK concentrations weremeasured
by a RIA, as described previously.19 The detection limit of the assay
is 0.3 pM. The intra-assay variation ranges from 4.6 to 11.5% and the
inter-assay variation from 11.3 to 26.1%.11
2.9. Emulsions
The emulsions consisted of 10% Canola oil (high oleic rapeseed
oil) in water. As emulsiﬁer 2.5% K-caseinate was used. A very small
amount of xanthan gum (0.1%) and guar gum (0.1%) was used as
stabiliser. Sodium chloride was added to obtain iso-osmotic solu-
tions (0.8% NaCl). The emulsions were standardized on a ﬁxed oil/
water ratio and a ﬁxed amount of emulsiﬁer. The variation indroplet size was obtained using high-shear mixers. The volume-
weighted mean diameter was 0.88 mm for the ﬁne emulsion and
15.5 mm for the coarse emulsion. The surface-weighted mean
diameter was 0.65 and 5.40, respectively, implying that droplet
surface was 5.4/0.65 ¼ 8.3 times larger for the ﬁne emulsion as
compared to the coarse one. Droplet size was measured using laser
diffraction by HELOS (helium-neon laser optical system). When
droplet sizes were measured after 2 months of storage, no change
in droplet size was observed. Also osmolarity (262 mOsm/kg), pH
(6.8) and viscosity (50 cP at 60 rpm at a Brookﬁeld DVII Viscometer)
were similar for both emulsions and this did not change after two
month of storage.
2.10. Statistical analysis
Results are presented as least squares means with standard
error (SE), unless otherwise speciﬁed. Satiety VAS scores were
expressed as percentages of the maximal score (0 cm equalled 0%
and 64 mm equaled 100%) and as cumulative areas under the curve
(AUC). The AUC was calculated using the trapezoid rule.
Parameters were analysed using analysis of covariance
(ANCOVA) with subjects as blocks and location (duodenum/ileum)
and size (ﬁne/coarse) as factors. The value of the parameter at the
start of each infusion (either at t ¼ 30 min or t ¼ 105 min) was used
as covariate. A p-value of 0.05 was considered signiﬁcant. The
timing for the duodenal (t ¼ 30e90 min after liquid meal) and ileal
infusions (105e165 min after liquid meal) was chosen as being in
the physiologic range of postprandial exposure to intraluminal
nutrients.14 However, as the timing of the duodenal and ileal
infusions was different, this precludes a direct comparison between
the duodenal and ileal infusion.
Gastrointestinal disturbances were analysed using frequency of
occurrence per time point and a standard ANOVAwith the personal
scores corrected for each subject’s overall mean score.
3. Results
The effects of droplet size on the different parameters are pre-
sented per site of fat infusion: results from duodenal infusions
followed by results from ileal infusions. As the other appetite scores
show comparable changes, only scores for fullness and hunger are
shown.
3.1. Duodenum
Fullness and hunger after the duodenal infusions are shown in
Fig. 2, starting from the onset of the duodenal infusions. Fasting
scores of fullness and hunger did not differ between treatments
(data not shown).
During the duo-ﬁne infusion, EVAS scores remained at the same
level until at least the end of the infusion (t ¼ 90 min), whereas
during the duo-coarse infusion, fullness scores started to decrease
and hunger scores started to increase already during the infusion.
Differences between treatments became signiﬁcant at the end of
the infusion period (fullness t ¼ 75, 90 min; hunger: t ¼ 105 min,
p < 0.05).
As shown in Fig. 2c,d, the AUC for fullness was signiﬁcantly
increased for duo-ﬁne vs duo-coarse, whereas the difference for
hunger was not statistically signiﬁcant between treatments.
3.2. Gastric emptying
In the duodenum, a signiﬁcant difference in gastric emptying half
time was observed between the Fine and Coarse treatment (148 vs.
129 min, SE ¼ 5, p < 0.05).
Fig. 2. Effect of droplet size on Fullness and Hunger after duodenal fat infusions (LSmeans  SEM, n ¼ 15). Duodenal infusion of either the ﬁne or coarse emulsion was scheduled
from t ¼ 30e90 min. *denotes p < 0.05, based on analysis by ANCOVA. a. Results for fullness in time. b. Results for fullness AUC. c. Results for hunger in time. d. Results for hunger
AUC.
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Fasting concentrations of CCK and PYY did not differ between the
two treatments (data not shown). Both infusions signiﬁcantly
increased plasma concentrations of CCK and PYY, but secretion of
these peptideswas not affected by the droplet size of the emulsions.
3.3. Ileum
For the ileal infusions, no signiﬁcant differences between the
two emulsions were seen for hunger and fullness (see Fig. 4).
Plasma concentrations and AUCs for CCK and PYY are given in
Fig. 5. Fasting concentrations and concentrations at t¼ 105min (the
start of infusion period) of CCK and PYY did not differ between the
two treatments (data not shown). In the ileum, both CCK and PYY
plasma concentrations were signiﬁcantly increased during the ﬁne
compared to the coarse infusion experiments. This resulted in
a signiﬁcantly higher AUC 105e240 min for CCK, whereas the
difference between treatments for the AUC for PYY did not reach
signiﬁcance.
In the ileum, gastric emptying half time did not differ between
the Fine and Coarse treatment (111 vs. 107 min, SE ¼ 5, NS).
Gastrointestinal complaints and general symptoms were not
signiﬁcantly different between treatments. Although there were
occasional symptoms, most of them were rated “mild” and some
were rated “moderate” (data not shown).
4. Discussion
Sensing of fatty acids in the small intestinal mucosa is a crucial
step for triacylglycerols to affect satiety and gastrointestinalsecretory and motor function. Upon exposure to fatty acids,
receptors in the mucosa can affect these parameters through
different pathways: they may secrete gut peptides such as CCK or
PYY, or they can directly activate neural (vagal) afferents. Secre-
tion of gut peptides or activation of vagal afferents then leads to
increased perception of satiety (after integration with signals
from other sources, such as the stomach) or a delay in gastric
emptying.1
In our present study, we hypothesized that reducing emulsion
droplet size would increase fatty acid sensing, leading to larger
effects on satiety, peptide secretion and gastric emptying.
Indeed, the effects of duodenal fat infusion on satiety scores
were signiﬁcantly more pronounced after the ﬁne compared to the
coarse emulsion. The ﬁne emulsion postponed the increase in
hunger and the reduction in fullness observed during the coarse
treatment.
We anticipated that the effect of droplet size would be more
prominent in the duodenum than in the ileum. Lipase is active on
the surface of a fat droplet, and a smaller droplet size will increase
the total emulsion surface area, thereby allowing the rate of fat
hydrolysis to increase. In a state of lipase abundancy, as is known to
exist in the duodenum, surface area will become the rate-limiting
step whereas in the ileum lipase is less abundant and therefore
will become the rate-limiting step.20 In the ileum, hunger was also
reduced and fullness increased after the ﬁne vs. coarse emulsion,
but these differences were not statistically signiﬁcant. With respect
to the duodenal infusions, our data conﬁrm the results found by
Seimon et al.,7 who showed that increasing emulsion surface area
by reducing emulsion droplet size resulted in increased effects on
satiety after duodenal infusion of a fat emulsion.
Fig. 3. Effect of droplet size on Cholecystokinin (CCK) and peptide YY (PYY) plasma concentrations after duodenal fat infusion (LSmeans  SEM, n ¼ 15). Duodenal fat infusion of
either the ﬁne or the coarse emulsion was scheduled from t ¼ 30e90 min. a. Results for plasma CCK concentrations in time. b. Results for CCK AUC. c. Results for plasma PYY
concentrations in time. d. Results for PYY AUC.
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did not observe an effect of droplet size on CCK release in our study
when fat was infused in the duodenum. This may be due to the fact
that at the start of the infusion, plasma CCK concentrations were
already elevated by ingestion of the breakfast meal.
When infused into the ileum, the ﬁne emulsion signiﬁcantly
increased plasma CCK concentrations. An identical pattern was
observed for PYY, although the integrated PYY secretion did not
differ signiﬁcantly between the ﬁne and coarse emulsion. As dis-
cussed above, the amount of intraluminal lipase in the duodenum is
abundant relative to the ileum. Generation of fatty acids with
subsequent release of peptides in the duodenum is not limited by
lipase activity, in contrast to the ileum. The observed effects on
peptide secretion after ileal infusions suggest that not the total
amount of FFA, but rather the rate of release of FFA is important for
release of these peptides. Therefore, the results on CCK and PYY
indicate that in the ileum, droplet size is the rate-limiting step with
the doses of fat administered in the present protocol.
Gastric emptying after duodenal fat infusion was signiﬁcantly
affected by emulsion droplet size. The ﬁne emulsion signiﬁcantly
delayed gastric emptying compared to the coarse emulsion, con-
ﬁrming the results of Armand et al.5 At the start of the duodenal
infusions (t ¼ 30 min), most of the meal still is present in the
stomach, whereas, at the start of the ileal infusions (t ¼ 105 min),
the meal will have largely emptied from the stomach. This will have
precluded the ileal infusion from signiﬁcantly affecting gastric
emptying.
A discrepancy seems to exist between the results obtained from
the duodenum and the ileum infusions. In the duodenumexperiments, the ﬁne emulsion increased satiety, but did not affect
CCK or PYY secretion, whereas in the ileum experiments, no
differences existed in satiety scores but the ﬁne emulsion signiﬁ-
cantly increased secretion of both CCK and PYY. Opposing results in
peptide secretion and satiety scores have been described previ-
ously.21,22 Recently, a team of researchers even concluded that none
of the currently known gut peptides is an adequate biomarker for
satiety.32 Gut peptides act locally as paracrine or neurocrine agents,
and not only as circulating hormones.23,24 Plasma concentrations of
peptides may therefore not truly reﬂect the local effects of these
peptides.1 Moreover, nutrients in the small intestine also have
a direct, non-peptide-mediated effect on neural afferents contrib-
uting to satiety.25 These intestinal signals interweave with signals
from the stomach, and are integrated in the satiety centres in the
brain.26,27 This interaction was demonstrated by Kissileff et al. who
showed that, in the presence of elevated plasma CCK concentra-
tions, additional distension of the stomach further reduces food
intake.28 During the duodenal infusions, gastric emptying was
more delayed in the ﬁne vs. the coarse infusion, resulting in
a more pronounced and prolonged gastric distension. We therefore
hypothesize that these differences in gastric distension have
contributed to the observed differences in satiety levels.
The physicochemical properties of nutrients affect the physio-
logical responses in the gastrointestinal tract to nutrients. Previous
studies have identiﬁed droplet size as a key physicochemical factor
in fatty acid bioavailability.33 Increasing droplet surface area for
availability to lipase molecules accelerates the process of digestion
of triacylglycerols and thereby of fatty acid bioavailability.33 For
instance, lipolysis of a 0.7 mm droplet emulsion was signiﬁcantly
Fig. 4. Effect of droplet size on Fullness and Hunger after ileal fat infusions (LSmeans  SEM, n ¼ 15). Ileal infusion of either the ﬁne or the coarse emulsion was scheduled from
t ¼ 105e165 min. a. Results for fullness after the ileal fat infusions. b. Results for fullness AUC after ileal fat infusions. AUC was calculated by trapezoid rule over t ¼ 105e240 min
period. c. Results for hunger after the ileal fat infusions. d. Results for hunger AUC after ileal fat infusions. AUC was calculated by trapezoid rule over t ¼ 105e240 min period.
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duodenum (73% vs 46%, p < 0.05).
We studied the effect of reducing fat droplet size on satiety by
direct infusion of emulsions into the small intestine. It is, however,
uncertain whether these effects will remain when the emulsions
are added to food products and then ingested orally as the gastric
environment can affect the stability of emulsions. Marciani et al.29
for instance, showed that gastric stable emulsions behave differ-
ently from gastric unstable emulsions, and this, in turn, can inﬂu-
ence the effects on peptide secretion and satiety scores.30 However,
in vitro and in vivo data suggest that the emulsions used in the
current study are acid stable,31 implying that the effects observed
after intestinal infusion would mimic effects after oral or gastric
infusion. However, when these emulsions are ingested orally, data
from Armand et al. suggest that passage through the stomach may
inﬂuence droplet size. Armand et al. observed an increase in the
average emulsion droplet size after intragastric administration of
an emulsion consisting of small droplets. This, however, might be
a measurement artifact as it may be the result of rapid hydrolysis of
the smaller fat droplets (and thus measurement of the remaining
bigger droplets). In contrast, a formula for pre-term infants has
been shown to maintain its median droplet diameter of 6 mm upon
passage through the stomach.34 This shows that smaller size
droplets remain present during passage through the stomach into
the small intestine. Upon arrival into the small intestine, the small
size fat droplets will increase the effective surface area available for
fat hydrolysis. This will result in a higher amount of fatty acids
present in the small intestine.5 As a threshold seems to exist above
which satiating effects of fat may be expected35 increasing theconcentration of fatty acids present at a given time in the small
intestine may increase the satiating effect of fat. Reducing droplet
size may achieve this goal. Droplet size may also inﬂuence other
physicochemical properties, such as formation of mixed micelles or
diffusion of lipids through the unstirred water layer. This in turn
may also affect exposure of epithelial receptors to fatty acids.5
The question arises how variations in lipid droplet size can be
implemented into daily nutrition. A diet that contains a high
percentage of smaller and stable lipid particles will have the
potency to more rapid fat digestion and induction of satiety. This
may be relevant in conditions with fat maldigestion such as
exocrine pancreatic insufﬁciency or in subjects with (morbid)
obesity to induce a more pronounced effect on satiety and eating
behaviour. On the other hand, in patients who are malnourished
and need additional nutritional support, satiety and food intake
should only be marginally affected and in such conditions larger
lipid droplet size may be advantageous with respect to eating
behaviour, in the assumption that digestion and absorption are not
compromised. Variations in droplet size exist in current daily
nutrition such as milk, infant formulae and enteral emulsions. A
wide range of lipid droplet sizes can be found, depending on the
product, from 0.3 to 20 mm.33 By varying physicochemical proper-
ties of fat one can steer the behaviour of fat in the gastrointestinal
tract e.g. its site of release or keeping the droplet size intact. The
physicochemical properties of fat not only include droplet size but
also fat globule organisation, lipid-droplet organisation and
molecular structure of triacylglycerols. More technical solutions are
currently becoming available such as encapsulation and nano-
particles but have not yet been implemented into daily nutrition.
Fig. 5. Effect of droplet size on Cholecystokinin (CCK) and peptide YY (PYY) plasma concentrations after ileal fat infusion (LSmeans  SEM, n ¼ 15). Ileal infusion of either the ﬁne or
the coarse emulsion was scheduled from t ¼ 105e165 min. *denotes p < 0.005, based on analysis by ANCOVA. a. Results for plasma CCK concentrations in time. b. Results for CCK
AUC. c. Results for plasma PYY concentrations in time. d. Results for PYY AUC.
P.W.J. Maljaars et al. / Clinical Nutrition 31 (2012) 535e542 541In conclusion, we have demonstrated that, compared to larger
fat droplets, smaller fat droplets signiﬁcantly affect satiety, gastric
emptying and gut peptide release, with the effect dependent on the
intestinal site of fat delivery. Thus, fat droplet size, through inﬂu-
encing fatty acid sensing, is relevant for satiety signalling and
regulation of GI function and secretion.
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